Literature DB >> 15042620

Murine prostate cancer inhibits both in vivo and in vitro generation of dendritic cells from bone marrow precursors.

Irina L Tourkova1, Kazuo Yamabe, Barbara Foster, Gurkamal Chatta, Lori Perez, Galina V Shurin, Michael R Shurin.   

Abstract

BACKGROUND: There is increasing evidence to suggest that dendritic cells (DC) are functionally impaired in tumor bearing hosts. However there is little or no data on the effects of murine prostate cancer (CaP) on DC generation from bone marrow precursors.
METHODS: Flow cytometry, mixed leukocyte reactions (MLR), and immunohistochemical analyses were used to characterize DC in CaP.
RESULTS: DC generated in the presence of CaP cell lines RM1 and the cell line C2 from the transgenic adenocarcinoma of the mouse prostate (TRAMP) mouse in a Transwell system expressed significantly lower levels of DC differentiation markers. This effect was confirmed when TK-neo-transfected RM1 cells were directly added to DC cultures and eliminated 5 days later using gancyclovir (GCV). Furthermore, co-incubation of DC with CaP cells resulted in a decrease in the stimulatory capacity of DC to induce T cell proliferation in the MLR assay. These results were further confirmed in vivo in two different murine models of CaP: i) DC generated from mice intrafemorally injected with TK-neo-transfected RM1 cells; and ii) in DC generated from TRAMP mice.
CONCLUSIONS: The generation and function of DC are significantly suppressed in the CaP microenvironment in both in vivo and in vitro murine models. Copyright 2004 Wileey-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15042620     DOI: 10.1002/pros.10369

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  6 in total

1.  Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.

Authors:  Hua Zhong; Dmitriy W Gutkin; Baohui Han; Yang Ma; Anton A Keskinov; Michael R Shurin; Galina V Shurin
Journal:  Int J Cancer       Date:  2014-01-20       Impact factor: 7.396

Review 2.  Optimization of immunotherapy in elderly cancer patients.

Authors:  Kei Tomihara; Tyler J Curiel; Bin Zhang
Journal:  Crit Rev Oncog       Date:  2013

3.  Alterations of dendritic cell subsets and TH1/TH2 cytokines in the peripheral circulation of patients with superficial transitional cell carcinoma of the bladder.

Authors:  Feng Lang; Ma Linlin; Tian Ye; Zhang Yuhai
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

4.  Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition.

Authors:  N Patrick McCabe; Maria Madajka; Amit Vasanji; Tatiana V Byzova
Journal:  Clin Exp Metastasis       Date:  2008-05-28       Impact factor: 5.150

Review 5.  Aging and the dendritic cell system: implications for cancer.

Authors:  Michael R Shurin; Galina V Shurin; Gurkamal S Chatta
Journal:  Crit Rev Oncol Hematol       Date:  2007-04-18       Impact factor: 6.312

6.  Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells.

Authors:  Irina L Tourkova; Galina V Shurin; Soldano Ferrone; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2008-08-28       Impact factor: 6.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.